Truist analyst David MacDonald raised the firm’s price target on Centene to $86 from $83 and keeps a Buy rating on the shares. The firm is adjusting its estimates to reflect the company’s updated Investor Day guidance announced last week.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CNC:
- Centene price target raised by $8 at Cantor Fitzgerald, here’s why
- Centene price target raised to $90 from $82 at Cantor Fitzgerald
- Ambetter of Illinois partners with RUSH University System for Health
- Centene price target raised by $6 at Jefferies, here’s why
- Centene price target raised by $4 at BofA, here’s why